BioCentury | Jul 9, 2001
Company News

Focal Inc., Genzyme Bio, Genzyme deal

...valued at $15.1 million based on GZBX's Friday close of $7.20 (see BioCentury, April 30). Focal Inc....
BioCentury | Apr 30, 2001
Company News

Focal Inc., Genzyme Bio, Genzyme deal

...$1.7 million in 2000. It had $3.8 million in cash as of Dec. 31, 2000. Focal Inc....
BioCentury | Apr 9, 2001
Company News

Focal Inc., J&J deal

...said the termination resulted from Ethicon's failure to meet certain purchase minimums by April 5. Focal Inc....
BioCentury | Jan 29, 2001
Company News

Focal Inc. board of directors update

Focal Inc. (FOCL), Lexington, Mass. Business: Biomaterial/Skin/Wound Transition: Donald Grilli to a director from chairman Resigned: Janet Effland and Jesse Treu WIR Staff Dermatology...
BioCentury | Jan 29, 2001
Company News

Focal Inc. management update

Focal Inc. (FOCL), Lexington, Mass. Business: Biomaterial/Skin/Wound Promoted: Ronald Rudowsky to president, CEO and a director from COO, he replaces Robert DePasqua, who becomes chairman WIR Staff Dermatology...
BioCentury | Dec 18, 2000
Company News

Focal Inc., Genzyme Surgical deal

...GZSP is to purchase an additional $5 million worth of FOCL shares under the deal. Focal Inc....
BioCentury | Nov 13, 2000
Company News

Focal Inc., Exactech Inc. deal

...medical devices for the orthopedic market, will retain global marketing rights to any resulting products. Focal Inc....
BioCentury | Jul 3, 2000
Finance

Lots of product stories

...to treat scalp dermatoses from Connetics Corp. (CNCT, Palo Alto, Calif.); FocalSeal-L surgical sealant from Focal Inc....
...to treat scalp dermatoses from Connetics Corp. (CNCT, Palo Alto, Calif.); FocalSeal-L surgical sealant from Focal Inc....
BioCentury | Jun 5, 2000
Company News

Focal Inc. deal

...by Ethicon Inc. (Cincinnati, Ohio), a division of Johnson & Johnson (JNJ, New Brunswick, N.J.). Focal Inc....
BioCentury | May 15, 2000
Clinical News

FocalSeal-L synthetic absorbable surgical sealant regulatory update

...North American distribution rights to FocalSeal-L, which is approved for marketing in Canada and Europe. Focal Inc....
Items per page:
1 - 10 of 57
BioCentury | Jul 9, 2001
Company News

Focal Inc., Genzyme Bio, Genzyme deal

...valued at $15.1 million based on GZBX's Friday close of $7.20 (see BioCentury, April 30). Focal Inc....
BioCentury | Apr 30, 2001
Company News

Focal Inc., Genzyme Bio, Genzyme deal

...$1.7 million in 2000. It had $3.8 million in cash as of Dec. 31, 2000. Focal Inc....
BioCentury | Apr 9, 2001
Company News

Focal Inc., J&J deal

...said the termination resulted from Ethicon's failure to meet certain purchase minimums by April 5. Focal Inc....
BioCentury | Jan 29, 2001
Company News

Focal Inc. board of directors update

Focal Inc. (FOCL), Lexington, Mass. Business: Biomaterial/Skin/Wound Transition: Donald Grilli to a director from chairman Resigned: Janet Effland and Jesse Treu WIR Staff Dermatology...
BioCentury | Jan 29, 2001
Company News

Focal Inc. management update

Focal Inc. (FOCL), Lexington, Mass. Business: Biomaterial/Skin/Wound Promoted: Ronald Rudowsky to president, CEO and a director from COO, he replaces Robert DePasqua, who becomes chairman WIR Staff Dermatology...
BioCentury | Dec 18, 2000
Company News

Focal Inc., Genzyme Surgical deal

...GZSP is to purchase an additional $5 million worth of FOCL shares under the deal. Focal Inc....
BioCentury | Nov 13, 2000
Company News

Focal Inc., Exactech Inc. deal

...medical devices for the orthopedic market, will retain global marketing rights to any resulting products. Focal Inc....
BioCentury | Jul 3, 2000
Finance

Lots of product stories

...to treat scalp dermatoses from Connetics Corp. (CNCT, Palo Alto, Calif.); FocalSeal-L surgical sealant from Focal Inc....
...to treat scalp dermatoses from Connetics Corp. (CNCT, Palo Alto, Calif.); FocalSeal-L surgical sealant from Focal Inc....
BioCentury | Jun 5, 2000
Company News

Focal Inc. deal

...by Ethicon Inc. (Cincinnati, Ohio), a division of Johnson & Johnson (JNJ, New Brunswick, N.J.). Focal Inc....
BioCentury | May 15, 2000
Clinical News

FocalSeal-L synthetic absorbable surgical sealant regulatory update

...North American distribution rights to FocalSeal-L, which is approved for marketing in Canada and Europe. Focal Inc....
Items per page:
1 - 10 of 57